These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8341227)

  • 1. [The efficacy of aztreonam in a "bolus dose" in the therapy of urinary tract infections in neonates].
    Fabris C; Licata D; Bertino E; Cavo L; Martano C
    Minerva Pediatr; 1993 Mar; 45(3):127-9. PubMed ID: 8341227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of aztreonam for complicated urinary tract infection].
    Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aztreonam in children with severe infections of the urinary tract].
    Rancilio L; Assael BM; Boccazzi A; Colombo R; Crossignani R; Garlaschi L; Rusconi F
    G Ital Chemioter; 1985; 32(2):437-41. PubMed ID: 3833586
    [No Abstract]   [Full Text] [Related]  

  • 4. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azthreonam in the treatment of urinary tract infection: evaluation of efficacy, renal effects and nephrotoxicity.
    Donadio C; Tramonti G; Garcea G; Lorusso P; Lucchetti A; Giordani R; Pierotti R; Falcone G; Bianchi C
    Drugs Exp Clin Res; 1987; 13(3):167-70. PubMed ID: 3622245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and tolerability of aztreonam in urinary tract infection caused by multiresistant bacteria.
    Muzzonigro G; Minardi D; Caraceni E; Villanova A; Polito M
    Acta Urol Belg; 1987; 55(3):485-90. PubMed ID: 3661329
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aztreonam in the treatment of infections of the urinary tract in childhood].
    Ravelli A; Fornari M; Visconti L; De Luca B; Nespoli L; Martini A
    G Ital Chemioter; 1985; 32(2):427-30. PubMed ID: 3833583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study on aztreonam in pediatrics].
    Niino M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1985 Nov; 38(11):3334-42. PubMed ID: 4094066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH; McCracken GH
    Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic effects and tolerance of aztreonam in infections of the urinary tract in childhood].
    Zappulla F; Mazzanti L; Sandri S; Varoli O; Bernardi F; Villa MP
    G Ital Chemioter; 1985; 32(2):433-6. PubMed ID: 3833585
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of aztreonam in the treatment of urinary infections in pediatrics].
    Impellizzeri A; Nicolosi VM; Raimondi A; Sortino C; Leocata A
    G Ital Chemioter; 1985; 32(2):431-2. PubMed ID: 3833584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the therapeutic effects of aztreonam and ceftazidime in the treatment of complicated infections of the urinary tract].
    Orani A; Sala A; Spandri A; Levi L; Invernizzi S; Malagola G
    G Ital Chemioter; 1985; 32(2):443-7. PubMed ID: 3914433
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections.
    Albertazzi A; Bonadio M; Fusaroli M; Lotti T; Miano L; Salvia G; Sasdelli M; Villa G; Zucchelli P; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():77-80. PubMed ID: 2659293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aztreonam in urinary tract infections].
    Gioè FP; Arcara M; Gucciardi A
    Clin Ter; 1986 Jun; 117(5):399-402. PubMed ID: 3742962
    [No Abstract]   [Full Text] [Related]  

  • 15. Employment of azthreonam in generalized and localized infections determined by gram negative bacteria.
    Terragna A; Giacchino R; Viscoli C; Consani G
    G Ital Chemioter; 1985; 32(2):423-5. PubMed ID: 3833582
    [No Abstract]   [Full Text] [Related]  

  • 16. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
    Martelli A; Cortecchia V; Ventriglia L
    Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experimentation with aztreonam in infections of the urinary tract].
    Martini G; Romano G; Pento C; Nubile G; Parogna A; Tresca E
    Minerva Urol Nefrol; 1986; 38(2):173-6. PubMed ID: 3750158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficiency and possibility of the use of aztreonam in bacterial infections caused by gram-negative organisms].
    Caramia G; Compagnoni L; Pettinari A; Gregorini S
    Minerva Pediatr; 1986 Sep; 38(17-18):773-7. PubMed ID: 3796535
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of gentamicin in single daily 160 mg dose in the treatment of urinary tract infections].
    Vela Navarrete R; Ales Reinlein JM; Torres Cid A
    Rev Clin Esp; 1976 Aug; 142(4):323-6. PubMed ID: 968118
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aztreonam in the treatment of nosocomial urinary infections].
    Nardini A; Taddei P; Rossi F
    G Ital Chemioter; 1986; 33(2-3):139-42. PubMed ID: 3678719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.